milgamma® 300mg film-coated tablets
MILGAMMA 300 mg Active ingredient: benfotiamine (thiamine prodrug) and vitamin B6.
MILGAMMA 300 mg Areas of application:
Neurological systemic diseases due to a proven deficiency of vitamins B1 and B6.
Suspected thiamine hypersensitivity, otherwise no known contraindications.
In individual cases allergic hypersensitivity reactions with skin reactions, hives (urticaria), states of shock.
Use during pregnancy and lactation:
No evidence of teratogenicity or mutagenicity. No concerns during breastfeeding in the specified dose range.
MILGAMMA 300 mg Interactions with other agents:
Therapeutic doses of vitamin B6 can weaken the effects of L-Dopa.
Further interactions exist with INH, D-penicillamine, cycloserine.